1. Home
  2. Analysis
  3. Omega-3-fatty-acids
  4. Omega-3-acid-ethyl-esters

Omega-3 fatty acids and Omega-3-acid ethyl esters drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 25 people who take Omega-3 fatty acids and Omega-3-acid ethyl esters. Common interactions include pneumonia aspiration among females, and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people who take Omega-3 fatty acids and Omega-3-acid ethyl esters have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

25 people who take Omega-3 fatty acids and Omega-3-acid ethyl esters together, and have interactions are studied.

What is Omega-3 fatty acids?

Omega-3 fatty acids has active ingredients of cod liver oil. It is used in high blood cholesterol. Currently, eHealthMe is studying from 2,285 Omega-3 fatty acids users.

What is Omega-3-acid ethyl esters?

Omega-3-acid ethyl esters has active ingredients of omega-3-acid ethyl esters. Currently, eHealthMe is studying from 1,625 Omega-3-acid ethyl esters users.

Number of Omega-3 fatty acids and Omega-3-acid ethyl esters reports submitted per year:

Omega-3 fatty acids and Omega-3-acid ethyl esters drug interactions.

Common Omega-3 Fatty Acids and Omega-3-Acid Ethyl Esters drug interactions by gender *:

female:

  1. Pneumonia aspiration
  2. Somnolence
  3. Abdominal discomfort
  4. Abdominal distension
  5. Abdominal pain
  6. Abdominal pain upper
  7. Amenorrhoea
  8. Arthralgia
  9. Arthritis
  10. Back pain

male:

  1. Acute myocardial infarction
  2. Coronary artery disease
  3. Hypertriglyceridaemia
  4. Myocardial infarction
  5. Hypertension
  6. Nasopharyngitis
  7. Salivary gland neoplasm
  8. Asthma

Common Omega-3 Fatty Acids and Omega-3-Acid Ethyl Esters drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Acute myocardial infarction
  2. Coronary artery disease
  3. Hypertriglyceridaemia
  4. Myocardial infarction

40-49:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Amenorrhoea
  4. Arthralgia
  5. Arthritis
  6. Back pain
  7. Blood growth hormone increased
  8. Blood pressure decreased
  9. Blood pressure systolic decreased
  10. Blood pressure systolic increased

50-59:

  1. Asthma

60+:

  1. Coma
  2. Gastrooesophageal reflux disease
  3. Pneumonia aspiration
  4. Somnolence
  5. Hypertension
  6. Nasopharyngitis
  7. Salivary gland neoplasm

Common conditions people have *:

  1. Pain: 17 people, 68.00%
  2. Hypertriglyceridaemia (excess of triglycerides in the blood): 2 people, 8.00%
  3. Hiv Infection: 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Omega-3 fatty acids and Omega-3-acid ethyl esters?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Omega-3 fatty acids drug interactions:

Browse interactions between Omega-3 fatty acids and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Omega-3-acid ethyl esters drug interactions:

Browse interactions between Omega-3-acid ethyl esters and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cod liver oil and omega-3-acid ethyl esters (the active ingredients of Omega-3 fatty acids and Omega-3-acid ethyl esters, respectively), and Omega-3 fatty acids and Omega-3-acid ethyl esters (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Omega-3 fatty acids and Omega-3-acid ethyl esters.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.